respiratory
ILD

New thinking on methotrexate: don’t delay treatment due to fears of ILD


A team of UK rheumatologists has urged clinicians to not delay treatment with methotrexate in rheumatoid arthritis because of fears over lung injury. In fact, use of methotrexate in a treat-to-target approach in patients with progressive disease may prevent the development...

A team of UK rheumatologists has urged clinicians to not delay treatment with methotrexate in rheumatoid arthritis because of fears...

Read more